🎉 In a collaboration between American Heart Association Ventures and the Associations’s Center for Health Technology and Innovation, eight companies have been selected to participate in the American Heart Association Heart and Brain Health Accelerator. The eight finalists have specific solutions and applications identified by experts for their potential to positively impact women’s cardiovascular and brain health outcomes – and three of them are StartUp Health community members: ⭐ Sinaptica Therapeutics: A medtech company developing a non-invasive, personalized brain stimulation therapy aimed at slowing the progression of Alzheimer's disease by enhancing memory-related brain networks ⭐ SynchNeuro, Inc.: A health tech company developing a non-invasive, behind-the-ear wearable device that uses brain signals to monitor blood sugar levels, aiming to help people with prediabetes manage their health without needles or implants ⭐ VERAVAS, Inc.: a health tech company that has developed a patented platform using magnetic beads to purify and concentrate biomarkers from complex samples like blood or saliva, enabling earlier and more accurate detection of diseases such as Alzheimer's These companies now also become official members of the MedTech Innovator program for this year, which includes access to networking opportunities, funding and increased visibility within the medical technology industry. In addition, they will receive specialized mentorship, coaching and capacity building from American Heart Association Ventures, customized to their focus on cardiovascular and/or brain conditions and diseases. As participants in the Heart and Brain Health Accelerator, these companies qualify to participate in the MedTech Innovator Competition Finals, held at the MedTech Conference on Oct 5-8, 2025, in San Diego, CA. Learn more ⤵️ https://bit.ly/3Us7i15 #HealthTransformer #HealthMoonshot #AlzMoonshot #Cardiometabolic
